Status:
RECRUITING
Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Vancouver Coastal Health Research Institute
Conditions:
Endometrial Cancer
Lynch Syndrome
Eligibility:
FEMALE
30+ years
Phase:
NA
Brief Summary
The goal of this study is to find out if self-collected vaginal swabs can be used to detect early signs of uterine cancer or related conditions in people with Lynch syndrome (LS) who still have their ...
Eligibility Criteria
Inclusion
- Diagnosed with Lynch syndrome (confirmed by genetic testing).
- Have an intact uterus.
- Age 30 years or older.
Exclusion
- History of endometrial cancer or endometrial hyperplasia.
- History of pelvic radiation or endometrial ablation.
- Pregnant at the time of study enrolment or during the study.
Key Trial Info
Start Date :
August 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07194551
Start Date
August 29 2025
End Date
April 1 2027
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VGH Research Pavilion
Vancouver, British Columbia, Canada, V5Z 1M9